Literature DB >> 15671684

Acanthopanax senticosus extract prepared from cultured cells decreases adiposity and obesity indices in C57BL/6J mice fed a high fat diet.

Youn-Soo Cha1, Soon-Jae Rhee, Young-Ran Heo.   

Abstract

The herb Acanthopanax senticosus was cultured from a cell suspension by a proprietary process, and evaluated for protective effects against obesity in C57BL/6J mice fed high fat diets. Forty 4-week-old male C57BL/6J mice (n = 10) were fed either a normal diet (10 kcal fat%) or high fat diet (60 kcal fat%) given with or without oral administration of A. senticosus extract (ASE; 0.5 g/kg of body weight) for 12 weeks. Feed consumption was not different among the groups, but energy intake was higher in the groups fed high fat diets than in the groups fed normal diets. Body weight gain, abdominal fat accumulation, and serum leptin concentrations were significantly higher in the high fat-fed groups than the other groups. Animals fed the high fat diet had significantly higher low-density lipoprotein (LDL)-cholesterol in serum and higher triglyceride accumulation in liver, but the ASE supplement restored both to the same levels as in the animals fed low fat diets. Total carnitine concentration were not significantly different between the two diet groups; also the oral administration of ASE did not alter carnitine status. Accordingly, the current results suggest the oral administration of ASE seemed to lower the weight gain, serum LDL-cholesterol concentration, and liver triglycerides accumulation in mice with obesity induced by high fat diets. These results seemed to suggest that supplementation with ASE might have a role in the prevention of obesity in high fat-fed mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15671684     DOI: 10.1089/jmf.2004.7.422

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  7 in total

1.  The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women.

Authors:  You-Cheol Hwang; In-Kyung Jeong; Kyu Jeung Ahn; Ho Yeon Chung
Journal:  J Bone Miner Metab       Date:  2009-05-20       Impact factor: 2.626

Review 2.  A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity.

Authors:  Shirin Hasani-Ranjbar; Neda Nayebi; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

3.  Mice lacking PLAP-1/asporin counteracts high fat diet-induced metabolic disorder and alveolar bone loss by controlling adipose tissue expansion.

Authors:  Hiromi Sakashita; Satoru Yamada; Masaki Kinoshita; Tetsuhiro Kajikawa; Tomoaki Iwayama; Shinya Murakami
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

4.  The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.

Authors:  Sonia A Tucci; Emma J Boyland; Jason Cg Halford
Journal:  Diabetes Metab Syndr Obes       Date:  2010-05-10       Impact factor: 3.168

Review 5.  Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects.

Authors:  Ravirajsinh Jadeja; Ranjitsinh V Devkar; Srinivas Nammi
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-03       Impact factor: 2.629

6.  Codonopsis lanceolata extract prevents diet-induced obesity in C57BL/6 mice.

Authors:  Jong Seok Lee; Kui-Jin Kim; Young-Hyun Kim; Dan-Bi Kim; Gi-Hae Shin; Ju-Hyun Cho; Bong Kyun Kim; Boo-Yong Lee; Ok-Hwan Lee
Journal:  Nutrients       Date:  2014-10-28       Impact factor: 5.717

7.  A Fomitopsis pinicola Jeseng Formulation Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity.

Authors:  Hoe-Yune Jung; Yosep Ji; Na-Ri Kim; Do-Young Kim; Kyong-Tai Kim; Bo-Hwa Choi
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-20       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.